Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany R King

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Cancer|February 5, 2022
Splitting signals drives CARs furtherTiffany R King-Peoples, Avery D Posey
Cancer Cell|October 16, 2020
Combination Therapy for Solid Tumors: Taking a Classic CAR on New AdventuresOula Dagher, Tiffany R King, Nils Wellhausen, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|February 15, 2021
Enabled/VASP is required to mediate proper sealing of opposing cardioblasts during Drosophila dorsal vessel formationTiffany R King, Joseph Kramer, Yi-Shan Cheng, et al.
Developmental Biology|June 21, 2014
Cdc42 is required in a genetically distinct subset of cardiac cells during Drosophila dorsal vessel closureDavid Swope, Joseph Kramer, Tiffany R King, et al.
Glycobiology|January 26, 2018
Glycan-directed CAR-T cellsCatharina Steentoft, Denis Migliorini, Tiffany R King, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Approaches of T Cell Activation and Differentiation for CAR-T Cell TherapiesRobert D Schwab, Darel Martínez Bedoya, Tiffany R King, et al.
Journal for Immunotherapy of Cancer|January 22, 2026
CD2 costimulation bridges potent CAR-induced cytolysis and durable persistenceFang Liu, John T Keane, Hyeon S Lewis, et al.
Analytical Chemistry|December 17, 2009
Effect of physicochemical anomalies of soda-lime silicate slides on biomolecule immobilizationStella H North, Evgeniya H Lock, Tiffany R King, et al.
Cancer Immunology Research|July 3, 2026
CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor ResistanceTiffany R King-Peoples, John T Keane, Hyeon-Gyu S Lewis, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Cancer|February 5, 2022
Splitting signals drives CARs furtherTiffany R King-Peoples, Avery D Posey
Cancer Cell|October 16, 2020
Combination Therapy for Solid Tumors: Taking a Classic CAR on New AdventuresOula Dagher, Tiffany R King, Nils Wellhausen, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|February 15, 2021
Enabled/VASP is required to mediate proper sealing of opposing cardioblasts during Drosophila dorsal vessel formationTiffany R King, Joseph Kramer, Yi-Shan Cheng, et al.
Developmental Biology|June 21, 2014
Cdc42 is required in a genetically distinct subset of cardiac cells during Drosophila dorsal vessel closureDavid Swope, Joseph Kramer, Tiffany R King, et al.
Glycobiology|January 26, 2018
Glycan-directed CAR-T cellsCatharina Steentoft, Denis Migliorini, Tiffany R King, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Approaches of T Cell Activation and Differentiation for CAR-T Cell TherapiesRobert D Schwab, Darel Martínez Bedoya, Tiffany R King, et al.
Journal for Immunotherapy of Cancer|January 22, 2026
CD2 costimulation bridges potent CAR-induced cytolysis and durable persistenceFang Liu, John T Keane, Hyeon S Lewis, et al.
Analytical Chemistry|December 17, 2009
Effect of physicochemical anomalies of soda-lime silicate slides on biomolecule immobilizationStella H North, Evgeniya H Lock, Tiffany R King, et al.
Cancer Immunology Research|July 3, 2026
CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor ResistanceTiffany R King-Peoples, John T Keane, Hyeon-Gyu S Lewis, et al.
Pageof 1